Is there a future for cell-penetrating peptides in oligonucleotide delivery?

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 1, 2013, Pages 5-11

  Lee, Soo Hyeon ^a   Castagner, Bastien ^a   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cell penetrating peptide; Delivery; Endocytosis; Oligonucleotide; siRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BEE VENOM; CELL PENETRATING PEPTIDE; GALANIN; GLYCOPROTEIN GP 41; LIPOSOME; LUCIFERASE; MASTOPARAN; POLYMER; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; VIRUS LARGE T ANTIGEN;

CELL SPECIFICITY; CONJUGATION; ENDOSOME; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROMOLECULE; NONHUMAN; NUCLEOTIDE TRANSPORT; PINOCYTOSIS; REACTION OPTIMIZATION; REVIEW; RNA BINDING; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; STRUCTURE ACTIVITY RELATION; TISSUE SPECIFICITY;

CELL-PENETRATING PEPTIDE; DELIVERY; ENDOCYTOSIS; OLIGONUCLEOTIDE; SIRNA;

ANIMALS; CELL-PENETRATING PEPTIDES; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOSOMES; GENE SILENCING; GENETIC THERAPY; HUMANS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION;

EID: 84882985069     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.03.021     Document Type: Review

References (98)

1. R. Kole, A.R. Krainer, and S. Altman RNA therapeutics: beyond RNA interference and antisense oligonucleotides Nat. Rev. Drug Discov. 11 2012 125 140
2. S. Yla-Herttuala Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union Mol. Ther. 20 2012 1831 1832
3. D. Bouard, N. Alazard-Dany, and F.L. Cosset Viral vectors: from virology to transgene expression Br. J. Pharmacol. 157 2009 153 165
4. Y. Zhang, A. Satterlee, and L. Huang In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol. Ther. 20 2012 1298 1304
5. M. Raouane, D. Desmaele, M. Gilbert-Sirieix, C. Gueutin, F. Zouhiri, C. Bourgaux, E. Lepeltier, R. Gref, R. Ben Salah, G. Clayman, L. Massaad-Massade, and P. Couvreur Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma J. Med. Chem. 54 2011 4067 4076
6. A.E. Felber, N. Bayo-Puxan, G.F. Deleavey, B. Castagner, M.J. Damha, and J.C. Leroux The interactions of amphiphilic antisense oligonucleotides with serum proteins and their effects on in vitro silencing activity Biomaterials 33 2012 5955 5965
7. A.M. Krieg, J. Tonkinson, S. Matson, Q. Zhao, M. Saxon, L.M. Zhang, U. Bhanja, L. Yakubov, and C.A. Stein Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy Proc. Natl. Acad. Sci. USA 90 1993 1048 1052
8. C. Wolfrum, S. Shi, K.N. Jayaprakash, M. Jayaraman, G. Wang, R.K. Pandey, K.G. Rajeev, T. Nakayama, K. Charrise, E.M. Ndungo, T. Zimmermann, V. Koteliansky, M. Manoharan, and M. Stoffel Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Nat. Biotechnol. 25 2007 1149 1157
9. A. Prochiantz Protein and peptide transduction, 20 years later a happy birthday Adv. Drug Deliv. Rev. 60 2008 448 451
10. G. Elliott, and P. O'Hare Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88 1997 223 233
11. A.D. Frankel, and C.O. Pabo Cellular uptake of the tat protein from human immunodeficiency virus Cell 55 1988 1189 1193
12. D. Derossi, A.H. Joliot, G. Chassaing, and A. Prochiantz The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 1994 10444 10450
13. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2009 195 206
14. E. Vivès, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017
15. M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, and G. Divita A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucl. Acids Res. 25 1997 2730 2736
16. M. Pooga, U. Soomets, M. Hallbrink, A. Valkna, K. Saar, K. Rezaei, U. Kahl, J.-X. Hao, X.-J. Xu, Z. Wiesenfeld-Hallin, T. Hokfelt, T. Bartfai, and U. Langel Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo Nat. Biotechnol. 16 1998 857 861
17. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
18. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. USA 97 2000 13003 13008
19. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
20. P. Järver, T. Coursindel, S.E.L. Andaloussi, C. Godfrey, M.J.A. Wood, and M.J. Gait Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA Mol. Ther. Nucl. Acids 1 2012 e27
21. J.S. Wadia, R.V. Stan, and S.F. Dowdy Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10 2004 310 315
22. R. Bartz, H. Fan, J. Zhang, N. Innocent, C. Cherrin, S.C. Beck, Y. Pei, A. Momose, V. Jadhav, D.M. Tellers, F. Meng, L.S. Crocker, L. Sepp-Lorenzino, and S.F. Barnett Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape Biochem. J. 435 2011 475 487
23. F. Salomone, F. Cardarelli, M. Di Luca, C. Boccardi, R. Nifosi, G. Bardi, L. Di Bari, M. Serresi, and F. Beltram A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape J. Control. Release 163 2012 293 303
24. Y.J. Lee, A. Erazo-Oliveras, and J.P. Pellois Delivery of macromolecules into live cells by simple co-incubation with a peptide Chembiochem 11 2010 325 330
25. E.-S. Khafagy, and M. Morishita Oral biodrug delivery using cell-penetrating peptide Adv. Drug Deliv. Rev. 64 2012 531 539
26. B.R. Meade, and S.F. Dowdy Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides Adv. Drug Deliv. Rev. 59 2007 134 140
27. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. USA 101 2004 17867 17872
28. L. Fei, L. Ren, J.L. Zaro, and W.C. Shen The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides J. Drug Target. 19 2011 675 680
29. M. Meyer, C. Dohmen, A. Philipp, D. Kiener, G. Maiwald, C. Scheu, M. Ogris, and E. Wagner Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate Mol. Pharm. 6 2009 752 762
30. D.G. Ahn, M.J. Kourakis, L.A. Rohde, L.M. Silver, and R.K. Ho T-box gene tbx5 is essential for formation of the pectoral limb bud Nature 417 2002 754 758
31. M.M. Fabani, C. Abreu-Goodger, D. Williams, P.A. Lyons, A.G. Torres, K.G.C. Smith, A.J. Enright, M.J. Gait, and E. Vigorito Efficient inhibition of miR-155 function in vivo by peptide nucleic acids Nucl. Acids Res. 38 2010 4466 4475
32. S. Abes, J.J. Turner, G.D. Ivanova, D. Owen, D. Williams, A. Arzumanov, P. Clair, M.J. Gait, and B. Lebleu Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide Nucl. Acids Res. 35 2007 4495 4502
33. F. Simeoni, M.C. Morris, F. Heitz, and G. Divita Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucl. Acids Res. 31 2003 2717 2724
34. S. El-Andaloussi, P. Jarver, H.J. Johansson, and U. Langel Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem. J. 407 2007 285 292
35. S. Boeckle, E. Wagner, and M. Ogris C-versus N-terminally linked melittin-polyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes J. Gene Med. 7 2005 1335 1347
36. B. Wu, H.M. Moulton, P.L. Iversen, J. Jiang, J. Li, J. Li, C.F. Spurney, A. Sali, A.D. Guerron, K. Nagaraju, T. Doran, P. Lu, X. Xiao, and Q.L. Lu Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer Proc. Natl. Acad. Sci. USA 105 2008 6
37. H.M. Moulton, and J.D. Moulton Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy Biochim. Biophys. Acta 1798 2010 2296 2303
38. B. Lebleu, H.M. Moulton, R. Abes, G.D. Ivanova, S. Abes, D.A. Stein, P.L. Iversen, A.A. Arzumanov, and M.J. Gait Cell penetrating peptide conjugates of steric block oligonucleotides Adv. Drug Deliv. Rev. 60 2008 517 529
39. F.A. Rogers, S.S. Lin, D.C. Hegan, D.S. Krause, and P.M. Glazer Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate Mol. Ther. 20 2012 109 118
40. P. Sazani, F. Gemignani, S.-H. Kang, M.A. Maier, M. Manoharan, M. Persmark, D. Bortner, and R. Kole Systemically delivered antisense oligomers upregulate gene expression in mouse tissues Nat. Biotechnol. 20 2002 1228 1233
41. E.V. Wancewicz, M.A. Maier, A.M. Siwkowski, K. Albertshofer, T.M. Winger, A. Berdeja, H. Gaus, T.A. Vickers, C.F. Bennett, B.P. Monia, R.H. Griffey, C.J. Nulf, J. Hu, D.R. Corey, E.E. Swayze, and G.A. Kinberger Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissue J. Med. Chem. 53 2010 3919 3926
42. K. Albertshofer, A.M. Siwkowski, E.V. Wancewicz, C.C. Esau, T. Watanabe, K.C. Nishihara, G.A. Kinberger, L. Malik, A.B. Eldrup, M. Manoharan, R.S. Geary, B.P. Monia, E.E. Swayze, R.H. Griffey, C.F. Bennett, and M.A. Maier Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid J. Med. Chem. 48 2005 6741 6749
43. A. Amantana, H.M. Moulton, M.L. Cate, M.T. Reddy, T. Whitehead, J.N. Hassinger, D.S. Youngblood, and P.L. Iversen Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate Bioconjug. Chem. 18 2007 1325 1331
44. S. Ganguly, B. Chaubey, S. Tripathi, A. Upadhyay, P.V. Neti, R.W. Howell, and V.N. Pandey Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element Oligonucleotides 18 2008 277 286
45. D.S. Youngblood, S.A. Hatlevig, J.N. Hassinger, P.L. Iversen, and H.M. Moulton Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells Bioconjug. Chem. 18 2007 50 60
46. M. Kosuge, T. Takeuchi, I. Nakase, A.T. Jones, and S. Futaki Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans Bioconjug. Chem. 19 2008 656 664
47. S. Deshayes, K. Konate, A. Rydstrom, L. Crombez, C. Godefroy, P.E. Milhiet, A. Thomas, R. Brasseur, G. Aldrian, F. Heitz, M.A. Munoz-Morris, J.M. Devoisselle, and G. Divita Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines Small 8 2012 2184 2188
48. L. Crombez, G. Aldrian-Herrada, K. Konate, Q.N. Nguyen, G.K. McMaster, R. Brasseur, F. Heitz, and G. Divita A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells Mol. Ther. 17 2009 95 103
49. S.E. Andaloussi, T. Lehto, I. Mager, K. Rosenthal-Aizman, II. Oprea, O.E. Simonson, H. Sork, K. Ezzat, D.M. Copolovici, K. Kurrikoff, J.R. Viola, E.M. Zaghloul, R. Sillard, H.J. Johansson, F. Said Hassane, P. Guterstam, J. Suhorutsenko, P.M. Moreno, N. Oskolkov, J. Halldin, U. Tedebark, A. Metspalu, B. Lebleu, J. Lehtio, C.I. Smith, and U. Langel Design of a peptide-based vector PepFect6 for efficient delivery of siRNA in cell culture and systemically in vivo Nucl. Acids Res. 39 2011 3972 3987
50. A. Eguchi, B.R. Meade, Y.C. Chang, C.T. Fredrickson, K. Willert, N. Puri, and S.F. Dowdy Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat. Biotechnol. 27 2009 567 571
51. K. Konate, L. Crombez, S. Deshayes, M. Decaffmeyer, A. Thomas, R. Brasseur, G. Aldrian, F. Heitz, and G. Divita Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery Biochemistry 49 2010 3393 3402
52. J.-M. Crowet, L. Lins, S. Deshayes, G. Divita, M. Morris, R. Brasseur, and A. Thomas Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo Biochim. Biophys. Acta 1828 2013 499 509
53. L. Crombez, M.C. Morris, S. Dufort, G. Aldrian-Herrada, Q. Nguyen, G. Mc Master, J.L. Coll, F. Heitz, and G. Divita Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth Nucl. Acids Res 37 2009 4559 4569
54. Y. Ren, H.W. Cheung, G. von Maltzhan, A. Agrawal, G.S. Cowley, B.A. Weir, J.S. Boehm, P. Tamayo, A.M. Karst, J.F. Liu, M.S. Hirsch, J.P. Mesirov, R. Drapkin, D.E. Root, J. Lo, V. Fogal, E. Ruoslahti, W.C. Hahn, and S.N. Bhatia Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4 Sci. Trans. Med. 4 2012 147ra112
55. M.C. Morris, E. Gros, G. Aldrian-Herrada, M. Choob, J. Archdeacon, F. Heitz, and G. Divita A non-covalent peptide-based carrier for in vivo delivery of DNA mimics Nucl. Acids Res. 35 2007 e49
56. J. Kim, S.H. Lee, J. Choe, and T.G. Park Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain J. Gene Med. 11 2009 804 812
57. R.H. Mo, J.L. Zaro, and W.-C. Shen Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy Mol. Pharm. 9 2012 299 309
58. E. Kleemann, M. Neu, N. Jekel, L. Fink, T. Schmehl, T. Gessler, W. Seeger, and T. Kissel Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI J. Control. Release 109 2005 299 316
59. J.S. Suk, J. Suh, K. Choy, S.K. Lai, J. Fu, and J. Hanes Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles Biomaterials 27 2006 5143 5150
60. C. Zhang, N. Tang, X. Liu, W. Liang, W. Xu, and V.P. Torchilin SiRNA-containing liposomes modified with polyarginine effectively silence the targeted gene J. Control. Release 112 2006 229 239
61. D. Mudhakir, H. Akita, I.A. Khalil, S. Futaki, and H. Harashima Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice Drug Metab. Pharmacokinet. 20 2005 275 281
62. T. Shiraishi, and P.E. Nielsen Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption Nat. Protoc. 1 2006 633 636
63. T.B. Wyman, F. Nicol, O. Zelphati, P.V. Scaria, C. Plank, and F.C. Szoka Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers Biochemistry 36 1997 3008 3017
64. S.H. Lee, S.H. Kim, and T.G. Park Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide Biochem. Biophys. Res. Commun. 357 2007 511 516
65. P. Lundberg, S. El-Andaloussi, T. Sutlu, H. Johansson, and U. Langel Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 21 2007 2664 2671
66. Y. Ren, S. Hauert, J.H. Lo, and S.N. Bhatia Identification and characterization of receptor-specific peptides for siRNA delivery ACS Nano 6 2012 8620 8631
67. M. Mae, S. El Andaloussi, P. Lundin, N. Oskolkov, H.J. Johansson, P. Guterstam, and U. Langel A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy J. Control. Release 134 2009 221 227
68. A. Rydstrom, S. Deshayes, K. Konate, L. Crombez, K. Padari, H. Boukhaddaoui, G. Aldrian, M. Pooga, and G. Divita Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles PLoS One 6 2011 e25924
69. C. Palm-Apergi, P. Lonn, and S.F. Dowdy Do cell-penetrating peptides actually "penetrate" cellular membranes? Mol. Ther. 20 2012 695 697
70. H. Hirose, T. Takeuchi, H. Osakada, S. Pujals, S. Katayama, I. Nakase, S. Kobayashi, T. Haraguchi, and S. Futaki Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells Mol. Ther. 20 2012 984 993
71. C. Palm-Apergi, A. Lorents, K. Padari, M. Pooga, and M. Hallbrink The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake FASEB J. 23 2009 214 223
72. A. Lorents, P.K. Kodavali, N. Oskolkov, Ü. Langel, M. Hällbrink, and M. Pooga Cell-penetrating peptides split into two groups based on modulation of intracellular calcium concentration J. Biol. Chem. 287 2012 16880 16889
73. J.P. Lim, and P.A. Gleeson Macropinocytosis: an endocytic pathway for internalising large gulps Immunol. Cell Biol. 89 2011 836 843
74. P. Kumar, H. Wu, J.L. McBride, K.E. Jung, M.H. Kim, B.L. Davidson, S.K. Lee, P. Shankar, and N. Manjunath Transvascular delivery of small interfering RNA to the central nervous system Nature 448 2007 39 43
75. S. Subramanya, M. Armant, J.R. Salkowitz, A.M. Nyakeriga, V. Haridas, M. Hasan, A. Bansal, P.A. Goepfert, K.K. Wynn, K. Ladell, D.A. Price, N. Manjunath, J. Kan-Mitchell, P. Shankar, Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA, Mol. Ther. 18 (2010) 2028-2037.
76. P. Kumar, H.S. Ban, S.S. Kim, H. Wu, T. Pearson, D.L. Greiner, A. Laouar, J. Yao, V. Haridas, K. Habiro, Y.G. Yang, J.H. Jeong, K.Y. Lee, Y.H. Kim, S.W. Kim, M. Peipp, G.H. Fey, N. Manjunath, L.D. Shultz, S.K. Lee, and P. Shankar T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 134 2008 577 586
77. T. Teesalu, K.N. Sugahara, V.R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. USA 106 2009 16157 16162
78. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, and E. Ruoslahti Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
79. L. Roth, L. Agemy, V.R. Kotamraju, G. Braun, T. Teesalu, K.N. Sugahara, J. Hamzah, and E. Ruoslahti Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 31 2012 3754 3763
80. A.A. Kale, and V.P. Torchilin Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes J. Drug Target. 15 2007 538 545
81. H. Mok, K.H. Bae, C.H. Ahn, and T.G. Park PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake Langmuir 25 2009 1645 1650
82. J.P.M. Motion, J. Nguyen, and F.C. Szoka Phosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds Angew. Chem. Int. Ed. Engl. 51 2012 9047 9051
83. M.B. Hansen, E. van Gaal, I. Minten, G. Storm, J.C. van Hest, and D.W. Lowik Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes J. Control. Release 164 2012 87 94
84. X. Zhang, L. Wan, S. Pooyan, Y. Su, C.R. Gardner, M.J. Leibowitz, S. Stein, and P.J. Sinko Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells Mol. Pharm. 1 2004 145 155
85. C. Foerg, U. Ziegler, J. Fernandez-Carneado, E. Giralt, and H.P. Merkle Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases Pharm. Res. 24 2007 628 642
86. R. Trehin, U. Krauss, R. Muff, M. Meinecke, A.G. Beck-Sickinger, and H.P. Merkle Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58) Pharm. Res. 21 2004 33 42
87. C. Foerg, and H.P. Merkle On the biomedical promise of cell penetrating peptides: limits versus prospects J. Pharm. Sci. 97 2008 144 162
88. K. Saar, M. Lindgren, M. Hansen, E. Eiríksdóttir, Y. Jiang, K. Rosenthal-Aizman, M. Sassian, and Ü. Langel Cell-penetrating peptides: a comparative membrane toxicity study Anal. Biochem. 345 2005 55 65
89. A.K. Cardozo, V. Buchillier, M. Mathieu, J. Chen, F. Ortis, L. Ladrière, N. Allaman-Pillet, O. Poirot, S. Kellenberger, J.S. Beckmann, D.L. Eizirik, C. Bonny, and F. Maurer Cell-permeable peptides induce dose- and length-dependent cytotoxic effects Biochim. Biophys. Acta 1768 2007 2222 2234
90. E. Bárány-Wallje, J. Gaur, P. Lundberg, Ü. Langel, and A. Gräslund Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo FEBS Lett. 581 2007 2389 2393
91. T. Sugita, T. Yoshikawa, Y. Mukai, N. Yamanada, S. Imai, K. Nagano, Y. Yoshida, H. Shibata, Y. Yoshioka, S. Nakagawa, H. Kamada, S.i. Tsunoda, and Y. Tsutsumi Comparative study on transduction and toxicity of protein transduction domains Br. J. Pharmacol. 153 2008 1143 1152
92. T. Holm, H. Räägel, S.E.L. Andaloussi, M. Hein, M. Mäe, M. Pooga, and Ü. Langel Retro-inversion of certain cell-penetrating peptides causes severe cellular toxicity Biochim. Biophys. Acta 1808 2011 1544 1551
93. G. Tünnemann, G. Ter-Avetisyan, R.M. Martin, M. Stöckl, A. Herrmann, and M.C. Cardoso Live-cell analysis of cell penetration ability and toxicity of oligo-arginines J. Pept. Sci. 14 2008 469 476
94. S. Fletcher, K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, J.P. Steinhaus, H.M. Moulton, P.L. Iversen, and S.D. Wilton Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse Mol. Ther. 15 2007 1587 1592
95. Y. Hayashi, J. Yamauchi, I.A. Khalil, K. Kajimoto, H. Akita, and H. Harashima Cell penetrating peptide-mediated systemic siRNA delivery to the liver Int. J. Pharm. 419 2011 308 313
96. T.S. Deas, C.J. Bennett, S.A. Jones, M. Tilgner, P. Ren, M.J. Behr, D.A. Stein, P.L. Iversen, L.D. Kramer, K.A. Bernard, and P.-Y. Shi In vitro resistance selection and in vivo efficacy of morpholino oligomers against west nile virus Antimicrob. Agents. Chemother. 51 2007 2470 2482
97. R. Burrer, B.W. Neuman, J.P.C. Ting, D.A. Stein, H.M. Moulton, P.L. Iversen, P. Kuhn, and M.J. Buchmeier Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models J. Virol. 81 2007 5637 5648
98. T.A. Aguilera, E.S. Olson, M.M. Timmers, T. Jiang, and R.Y. Tsien Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides Integr. Biol. (Camb) 1 2009 371 381